Clinical trial · Observational
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer (ORIEN)
NCT03617939CI-TRIAL-00097119recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is not a treatment study. The overall objective is to develop an improved standard of care through studying blood, tissue, biological, etc. samples, that patients have allowed researchers to procure.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Risk | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biospeciman Collection | Procedure | — | UNRESOLVED |
| Medical Chart Reviews | Other | — | UNRESOLVED |
| Survey Assessments | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Biospeciman and Data Collection
- description
- Patients with cancer or who are at risk of having cancer who have given consent to have blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) collected and stored for the advancement of medicine.
- interventionNames
- Procedure: Biospeciman Collection
- Other: Survey Assessments
- Other: Medical Chart Reviews
Primary outcomes (7)
- measure
- Improve Standard of Cancer Care
- timeFrame
- Up to 20 years
- description
- Establish a longitudinal clinical and related data and tissue repository that will contain patient demographics via surveys and questionnaires.
- measure
- Improve Standard of Cancer Care
- timeFrame
- Up to 20 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. 18 years of age and older. 2. Diagnosed with cancer, or may be at risk for cancer. 3. Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through a legally authorized representative (LAR). Non-English speaking subjects will also be invited to participate in the TCCP study, in accordance with COMIRB's short-form consent use. Exclusion Criteria: 1\. Members of vulnerable populations including neonates (birth to 30 days), children (under age 18), wards of the State, prisoners or those on probation or alternate sentencing, or decisionally challenged (adults or children that are cognitively impaired, incompetent to consent, proxy consent, or consenting in life threatening situations).
References
Publications (0)
Data not yet available
No reference posted for this study.